APA (7th ed.) Citation

Liu, M., Liu, Z., He, S., Pei, Y., Xu, S., Ge, J., . . . Peng, X. Corrigendum: Development and validation of nomogram models for predicting immune-related adverse events in recurrent and metastatic nasopharyngeal carcinoma patients treated with PD-L1 inhibitors. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Liu, Mengyuan, et al. Corrigendum: Development and Validation of Nomogram Models for Predicting Immune-related Adverse Events in Recurrent and Metastatic Nasopharyngeal Carcinoma Patients Treated with PD-L1 Inhibitors. Frontiers Media S.A.

MLA (9th ed.) Citation

Liu, Mengyuan, et al. Corrigendum: Development and Validation of Nomogram Models for Predicting Immune-related Adverse Events in Recurrent and Metastatic Nasopharyngeal Carcinoma Patients Treated with PD-L1 Inhibitors. Frontiers Media S.A.